메디데이터, ‘넥스트 이노베이션 데이 서울’에서 AI 기반 임상시험 플랫폼 전략 발표

Medidata's comprehensive AI integration strategy directly tackles the clinical trial industry's critical pain points—90% trial failure rates and 80% halted due to patient recruitment failures. By embedding AI across the entire trial lifecycle, from protocol optimization through virtual simulation to real-time data quality management, the company is dramatically reducing trial duration and costs. This platform-wide AI approach accelerates drug development cycles while significantly improving patient experience, enabling life-saving medicines to reach patients faster.